Azithromycin's role in COVID-19 outcomes: Antibacterial or antiviral action?

Respir Med. 2025 Jan:236:107902. doi: 10.1016/j.rmed.2024.107902. Epub 2024 Dec 2.

Authors

Chia Siang Kow¹, Dinesh Sangarran Ramachandram², Syed Shahzad Hasan¹, Kaeshaelya Thiruchelvam³

Affiliations

¹ School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.
² School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
³ School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. Electronic address: [email protected].

PMID: 39631549
DOI: 10.1016/j.rmed.2024.107902

No abstract available

Keywords: Antibiotic; Azithromycin; COVID-19; ICU; bacterial.

Publication types

Letter